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Purpose: Peak oxygen uptake (peak VO2) and ventilatory inefficiency (VE/VCO2 
slope) have proven to be strong prognostic markers in patients with chronic heart 
failure (CHF). Recently increased red cell distribution width (RDW) has emerged 
as an additional predictor of poor outcome in CHF. We sought to evaluate the rela-
tionship between RDW and cardiopulmonary exercise test (CPET) parameters in 
CHF patients and healthy controls. Materials and Methods: 85 ambulatory CHF 
patients (68 men, 54±10 years) and 107 healthy controls, who underwent a symp-
tom-limited CPET on a treadmill according to the modified Bruce ramp protocol, 
were enrolled. CHF patients and healthy controls were divided into RDW tertile 
groups and laboratory, echocardiographic, and CPET results were analyzed. Re-
sults: For patients with CHF, compared with patients in the lowest RDW tertile, 
those in the highest tertile had lower peak VO2 (22 mL/kg/min vs. 28 mL/kg/min, 
p<0.001) and higher VE/VCO2 slope (31 vs. 25, p=0.004). Multivariate regression 
analysis revealed RDW to be an independent predictor for peak VO2 (β=-0.247, 
p=0.035) and VE/VCO2 slope (β=0.366, p=0.004). The optimal cutoff value of 
RDW for predicting peak VO2 ≤20 mL/kg/min and VE/VCO2 slope ≥34 was 
13.6% (sensitivity 53%, specificity 89%) and 13.4% (sensitivity 75%, specificity 
82%), respectively. In contrast, for healthy controls, RDW was not related to both 
peak VO2 and VE/VCO2 slope. Conclusion: Higher RDW is independently relat-
ed to peak VO2 and VE/VCO2 slope only in patients with CHF. RDW assessment, 
an inexpensive and simple method, might help predict functional capacity and 
ventilatory efficiency in these patients.
Key Words:   Cardiopulmonary exercise test, heart failure, red cell distribution 
width
INTRODUCTION
The cardiopulmonary exercise test (CPET) is an important clinical tool used to de-
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underwent CPET in the same periods. They did not have 
any cardiovascular risk factors such as hypertension, diabe-
tes or dyslipidemia.
The institutional review board of Yonsei University Col-
lege of Medicine approved the study protocol. 
Laboratory and echocardiographic measurements
Blood samples were obtained after an 8-h overnight fast by 
venipuncture into plain and EDTA tubes. Patients had ve-
nous blood collected for the measurement of routine blood 
chemistry. Using the Advia 2120i automated analyzer (Sie-
mens Healthcare Diagnostics, Deerfield, IL, USA), hema-
tologic variables such as hemoglobin, hematocrit, mean 
corpuscular volume, and RDW were measured. The refer-
ence range for RDW in our laboratory was 11.5-14.5%. Re-
nal function was determined by estimated glomerular filtra-
tion rate using the Modification of Diet in Renal Disease 
formula.13
Two-dimensional echocardiographic findings were ob-
tained. LVEF was measured using the modified Quinones 
method.14 In patients who had regional wall motion abnor-
malities, LVEF was calculated by the biplane Simpson’s 
method using apical four and two-chamber views.15 Left 
atrial volume index (LAVI) was measured using the prolate 
ellipsoid method.16 Pulsed-wave Doppler echocardiography 
of mitral inflow and tissue Doppler imaging from the apical 
four-chamber view with 2- to 5-mm sample volumes placed 
at the septal corner of the mitral annulus were used to deter-
mine the peak velocity of early diastolic filling (E), late fill-
ing (A), peak systolic velocity (S’) and early diastolic veloc-
ity (E’).17 Systolic pulmonary artery pressure was estimated 
from tricuspid regurgitation velocity by adding the right atri-
al pressure.
Cardiopulmonary exercise testing
A symptom-limited CPET was performed on a treadmill 
according to the modified Bruce ramp protocol. Patients 
were strongly encouraged to achieve a peak respiratory ex-
change ratio (RER) >1.10. Expired gases were collected 
continuously throughout exercise and analyzed for ventila-
tor volume, oxygen (O2) content, and carbon dioxide (CO2) 
content using a calibrated metabolic cart (Quark CPET, 
COSMED, Chicago, IL, USA). Expired gases were report-
ed every 15 s. During the exercise test, monitoring consist-
ed of continuous 12-lead electrocardiography, manual 
blood pressure measurements every stage, and heart rate 
(HR) recordings every stage via the electrocardiogram. 
termine the severity and prognosis of heart failure (HF). 
Among the various CPET parameters, peak oxygen uptake 
(peak VO2) and ventilatory response to exercise (VE/VCO2 
slope), measured by the slope of the increase in ventilation 
with respect to CO2 output, have been demonstrated to have 
a prognostic significance as indices of exercise capacity and 
ventilatory efficiency.1-3
Red cell distribution width (RDW), a measure of size 
variability among red blood cells, has been found to be a 
prognostic marker in patients with HF and acute dyspnea.4-8 
Although the mechanism for the association between in-
creased RDW and poor prognosis in HF is not clearly elu-
cidated, chronic inflammation, kidney dysfunction, hepatic 
congestion, and nutritional deficiencies in HF were suggest-
ed for the underlying mechanism for the increased RDW.9-12 
Therefore, we hypothesized that a higher RDW, which rep-
resents an increased severity of and an adverse prognosis 
for HF, would be related to exercise intolerance or ventila-
tory inefficiency, the measurements reflecting the severity 
of HF, especially in patients with chronic HF (CHF). In con-
trast, for control subjects who have much less conditions 
for increased RDW, it might be less related to exercise in-
tolerance or ventilatory inefficiency compared to those with 
CHF. Therefore, the present study evaluated the relationship 
between RDW and CPET parameters, especially peak VO2 





We retrospectively identified 1038 patients who underwent 
CPET between August 2011 and June 2012. Among them, 
we consecutively enrolled 120 CHF patients all in stable 
clinical condition with regard to symptoms and therapy for 
at least 3 months and with a left ventricular ejection fraction 
(LVEF) ≤55%. Patients with known hematologic diseases, 
neoplastic metastases to bone marrow, pregnancy, severe ar-
thritis, inflammatory bowel diseases, chronic obstructive pul-
monary disease, transfusion, iron replacement therapy (which 
can increase plasma RDW levels), and other extracellular 
fluid increasing diseases (e.g. hypothyroidism and liver cir-
rhosis) were excluded. A total of 35 patients without labora-
tory test results within 3 months from the CPET examina-
tions were excluded, and the final analysis included 85 
CHF patients. Also, we analyzed 107 healthy controls that 
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Baseline characteristics according to tertile subgroups of 
RDW are summarized in Table 1 for patients with CHF and 
in Table 2 for healthy controls. For patients with CHF, the 
highest tertile group tended to be older, leaner and had a 
more severe New York Heart Association functional classi-
fication. Regarding laboratory findings, the highest tertile 
group had significantly lower average albumin levels com-
pared to the lowest tertile group. Also, the highest tertile 
group had lower hemoglobin and higher uric acid. With re-
gard to echocardiographic indices, LVEF was not different 
among three groups. However, S’ velocity was lower in the 
highest tertile group with a marginal significance. LAVI was 
significantly different among the three groups with the high-
est value in the highest tertile group. Also, A’ velocity was 
lowest in the highest tertile group. E/E’ was higher in the 
highest tertile group compared with the lowest tertile group. 
Lastly, estimated systolic pulmonary artery pressure was 
significantly elevated in the highest tertile group than the 
lowest tertile group (23.3±6.6 mm Hg vs. 24.7±4.7 mm Hg 
vs. 31.0±16.1 mm Hg, p=0.031).
In healthy controls, most subjects had RDW levels of the 
reference range (11.5-14.5%). However, eight subjects had 
higher RDW levels than the reference range. Age, hemo-
globin, albumin levels, and E/E’ were significantly different 
among three groups in the healthy controls (Table 2). 
Cardiopulmonary exercise test data
When we analyzed the patients with CHF, exercise duration 
was significantly shorter in the highest tertile group com-
pared with the lowest tertile group (Table 3). The RDW 
level had a graded relationship with maximal workload, 
peak VO2 and VE/VCO2 slope. The highest tertile group 
had highest VE/VCO2 slope compared with the lowest ter-
tile group. There were no differences in peak RER, baseline 
HR, peak HR, and HRR during exercise among the three 
groups (Table 3).
However, when we analyzed the healthy controls, exer-
cise duration, maximal workload, and peak VO2 were not 
different according to the RDW tertile groups. Only VE/
VCO2 slope, peak HR and HRR were significantly different 
according to the RDW tertile groups. Similar to the patients 
with CHF, the highest tertile group had highest VE/VCO2 
slope compared with the lowest tertile group in healthy con-
CPET was terminated according to following criteria; pa-
tient request, ventricular tachycardia, ≥2 mm of horizontal 
or down-sloping ST segment depression or a drop in systol-
ic blood pressure ≥20 mm/Hg during exercise. A qualified 
exercise physiologist with physician supervision conducted 
each test.
The following variables were derived from the CPET re-
sults: peak oxygen consumption (peak VO2); peak RER, de-
fined by the ratio of CO2 production to O2 consumption at 
peak effort; VE/VCO2 slope, defined as the slope of the in-
crease in peak ventilation/increase in CO2 production through-
out exercise. Peak RER had the highest 30-s averaged value 
during the last stage of the test. Heart rate reserve (HRR) 
was defined as the difference between basal and peak HR.
Statistical analysis
Continuous variables are expressed as mean±standard devi-
ation and categorical variables as numbers and percentages. 
RDW values were treated as categorical variables in tertile 
groups because RDW was not normally distributed even 
after a log transformation. To compare baseline variables 
among RDW tertile groups, we used ANOVA for continu-
ous variables and the chi-square test for categorical vari-
ables. Simple linear regression analysis was performed to 
assess the relationship between CPET parameters and other 
clinical, laboratory, and echocardiographic parameters. The 
independent predictors of peak VO2 and VE/VCO2 slope 
were assessed by a multiple linear regression, performed on 
the clinical and laboratory covariates identified in previous 
published studies as affecting to peak VO2 and VE/VCO2 
slope.2,18,19 All analyses were performed for patients with 
CHF and for healthy controls.
To test the statistical significance of adding RDW to oth-
er clinical and laboratory parameters for prediction of out-
comes, we compared a model with RDW (full model) with 
a model without RDW (reduced model) using R2, adjusted 
R2 and the root mean square error (RMSE). Finally, the pre-
dictive power of RDW for identifying patients with peak 
VO2 ≤20 mL/kg/min and VE/VCO2 slope ≥34 was quanti-
fied in terms of the area under the receiver operating char-
acteristic (ROC) curve. Peak VO2 ≤20 mL/kg/min and VE/
VCO2 slope ≥34 were one of the most commonly suggest-
ed dichotomous threshold values for poor prognosis in 
CHF.3,20
All analyses were conducted using SPSS Statistics (ver-
sion 18.0.0, IBM Corp., Armonk, NY, USA). A p value of 
less than 0.05 was considered statistically significant.
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patients with CHF, peak VO2 level was significantly corre-
lated with age (β=-0.3, p=0.006), male gender (β=0.2, 
p=0.022), hemoglobin level (β=0.3, p=0.004), albumin lev-
el (β=0.3, p=0.002), LVEF (β=0.3, p=0.004), E/E’ (β=-0.4, 
p<0.001) and RDW tertile groups (Table 4). With regard to 
trols (Table 3).
Relationship between CPET parameters and clinical, 
laboratory, or echocardiographic parameters
When data were analyzed using simple linear regression for 
Table 1. Baseline Characteristics of Patients with CHF According to Tertile of RDW
 










Age (yrs)     51±10     56±10     55±10 0.069
Male 27 (90) 23 (77) 18 (72) 0.214
BMI (kg/m2)   25.6±2.4   26.6±4.1   24.0±3.1 0.018
NYHA classification 0.115
    I 22 (73) 22 (73) 11 (44)
    II   7 (23)   8 (27) 13 (52)
    III 1 (3) 0 (0) 1 (4)
Ischemic etiology 15 (50) 16 (53) 11 (44) 0.786
Underlying disease 
    Hypertension 11 (37) 13 (43)   8 (32) 0.682
    Diabetes mellitus   9 (30)   6 (20)   5 (20) 0.583
Medications
    Beta blockers 22 (73) 24 (80) 12 (48) 0.030
    ACE inhibitors   8 (27) 10 (33)   7 (28) 0.837
    ARBs 16 (53) 14 (47) 14 (56) 0.770
    CCBs   4 (13) 2 (7)   5 (20) 0.340
    Diuretics 14 (47) 12 (40) 18 (72) 0.048
Laboratory findings
    Hemoglobin (g/dL)   14.8±1.3   14.5±1.4   13.8±2.2 0.063
    RDW (%)   12.3±0.3   13.0±0.1   14.3±1.6 <0.001
    Sodium (mmol/L) 140±3 141±2 141±2 0.722
    Uric acid (mg/dL)     5.8±1.0     6.2±1.6     6.1±1.5 0.484
    Cholesterol (mg/dL)   161±36   162±30   154±32 0.677
    eGFR (mL/min/1.73 m2)     82±15     77±14     76±16 0.232
    Albumin (g/dL)     4.5±0.4     4.3±0.2     4.2±0.3 0.002
     Ln hsCRP (mg/L)      0.27±1.24      0.58±1.10      0.44±1.17 0.654
Echocardiographic indices
    LVEF (%)   39±9     38±11     36±11 0.511
    LVEDD (mm)   58±8     60±10   60±8 0.758
    LVESD (mm)   47±9     47±11   48±9 0.853
    LAVI (mL/m2)     29±10   31±7     43±23 0.002
    E velocity (cm/s)     0.65±0.19     0.57±0.19     0.74±0.31 0.030
    S’ (cm/s)     5.4±1.4     4.8±1.5     4.6±1.7 0.159
    E’ (cm/s)     6.3±2.8     4.4±1.4     4.6±1.6 0.003
    A’ (cm/s)     7.8±1.8     7.1±1.7     6.0±2.4 0.007
    E/E’   12.0±5.5   13.9±6.9     16.5±10.2 0.110
    Systolic PAP (mm Hg)   23.3±6.6   24.7±4.7     31.0±16.1 0.031
RDW, red cell distribution width; BMI, body mass index; NYHA, New York Heart Association; ACE, angiotensin converting enzyme; ARB, angiotensin II 
receptor blocker; CCB, calcium channel blocker; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; LVEDD, left ventricular 
end-diastolic dimension; LVESD, left ventricular end-systolic dimension; PAP, pulmonary artery pressure; CHF, chronic heart failure; LAVI, left atrial volume 
index; hsCRP, high-sensitivity C-reactive protein.
Values are mean±SD or number (%). 
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Age (yrs)     41±17     44±16     50±16 0.052
Male 21 (58) 20 (59) 13 (35) 0.070
BMI (kg/m2)   22.1±3.1   22.7±3.7   22.1±3.3 0.724
Laboratory findings
    Hemoglobin (g/dL)   14.7±1.4   14.3±1.1   13.6±2.2 0.017
    RDW (%)   12.3±0.3   12.8±0.1   14.2±2.7 <0.001
    Sodium (mmol/L) 141±2 141±2 141±2 0.977
    Uric acid (mg/dL)     4.8±1.0     4.9±1.2     4.9±1.5 0.984
    Cholesterol (mg/dL)   183±35   189±29   188±43 0.784
    eGFR (mL/min/1.73 m2)     98±14   101±15     92±19 0.077
    Albumin (g/dL)     4.5±0.2     4.3±0.2     4.3±0.3 0.011
Echocardiographic indices
    LVEF (%)   66±6   67±5   66±6 0.915
    LVEDD (mm)   47±4   47±3   48±4 0.510
    LVESD (mm)   31±3   31±3   32±3 0.514
    LAVI (mL/m2)   21±6   20±5   23±6 0.117
    E velocity (cm/s)     0.64±0.13     0.64±0.13     0.68±0.15 0.325
    A velocity (cm/s)     0.50±0.15     0.56±0.13     0.58±0.18 0.073
    E/E’     7.0±1.6     8.0±1.7     8.4±2.3 0.001
RDW, red cell distribution width; BMI, body mass index; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; LVEDD, left ven-
tricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LAVI, left atrial volume index.   
Values are mean±SD or number (%). 
Table 3. Cardiopulmonary Exercise Testing of Patients with CHF and Healthy Controls
RDW tertile 1 RDW tertile 2 RDW tertile 3 p value
Patients with CHF
    Exercise duration (s)   739±167   636±191   534±170 <0.001
    Max. workload (METs)   8.1±1.8   7.1±1.7   6.2±1.5 <0.001
    Peak VO2 (mL/kg/min) 28.3±6.2 24.9±5.9 21.7±5.2 <0.001
    VE/VCO2 slope 25.3±3.6 27.8±4.6 31.0±8.4 0.002
    Peak RER   1.16±0.14   1.13±0.11   1.08±0.13 0.096
    Baseline HR (bpm)   78±20   77±10   77±16 0.994
    Peak HR (bpm) 155±30 145±18 144±25 0.205
    HRR (bpm)   77±24   68±17   67±24 0.147
Healthy controls
    Exercise duration (s)   806±177   810±133   746±195 0.212
    Max. workload (METs)   9.2±2.2   9.2±1.9   8.6±2.1 0.394
    Peak VO2 (mL/kg/min) 32.2±7.6 32.2±6.7 30.2±7.3 0.381
    VE/VCO2 slope 27.6±3.3 27.5±2.7 29.6±5.4 0.045
    Peak RER   1.13±0.09   1.15±0.09   1.10±0.12 0.074
    Baseline HR (bpm)   74±12   72±12   72±11 0.588
    Peak HR (bpm) 166±22 169±18 155±25 0.025
    HRR (bpm)   92±20   97±14   84±24 0.027
Max, maximal; RER, respiratory exchange ratio; HR, heart rate; HRR, heart rate reserve; CHF, chronic heart failure; RDW, red cell distribution width; MET, 
metabolic equivalent.
Values are mean±SD.
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For prediction of both peak VO2 and VE/VCO2 slope, the 
R2 and adjusted R2 of the full model was greater than those 
of the reduced model and the RMSE of the full model was 
less than that of the reduced model (Table 5). ROC curve 
indicated a good power of RDW in identifying patients with 
peak VO2 ≤20 mL/kg/min and VE/VCO2 slope ≥34 [area 
under the curve 0.717, 95% confidence interval (CI)=0.556-
0.878 for peak VO2 and AUC 0.858, 95% CI=0.747-0.970 
for VE/VCO2 slope] (Fig. 1). The optimal cutoff value of 
RDW for predicting peak VO2 ≤20 mL/kg/min and VE/
VCO2 slope ≥34 was 13.6% (sensitivity 53%, specificity 
89%) and 13.4% (sensitivity 75%, specificity 82%), respec-
tively.
DISCUSSION
The principal findings of this study are that 1) higher RDW 
is related to lower exercise capacity with lower peak VO2 
ventilatory inefficiency for patients with CHF, VE/VCO2 
slope was also significantly correlated with age (β=0.2, 
p=0.033), body mass index (BMI) (β=-0.3, p=0.007), hemo-
globin level (β=-0.3, p=0.015), albumin level (β=-0.3, 
p=0.002), LVEF (β=-0.4, p=0.001), E/E’ (β=0.4, p<0.001) 
and RDW tertile groups (Table 5). 
However, notably in healthy controls, peak VO2 level and 
VE/VCO2 slope did not significantly correlated with RDW 
tertile groups (Table 4).
Independent predictors for peak VO2 and VE/VCO2 
slope
Multiple linear regression analysis demonstrated an inde-
pendent association between peak VO2 and RDW tertile 
groups (Table 4). BMI and E/E’ were other independent 
predictors of peak VO2. Similarly, an independent associa-
tion between VE/VCO2 slope and RDW tertile groups was 
observed (Table 4). Also, E/E’ was another independent 
predictor of VE/VCO2 slope. 
Table 4. Univariate and Multivariate Analysis for Peak VO2 and VE/VCO2 Slope
Univariate Multivariate
β (SE) p value β (SE) p value
Peak VO2
    Patients with CHF
        RDW tertile 2 -0.030 (1.45)   0.783 -0.094 (1.45) 0.393
        RDW tertile 3 -0.353 (1.42)   0.001 -0.247 (1.65) 0.035
    Healthy controls
        RDW tertile 2  0.070 (1.50)   0.471  0.057 (1.21) 0.499
        RDW tertile 3 -0.136 (1.46)   0.164  0.016 (1.45) 0.874
VE/VCO2 slope
    Patients with CHF
        RDW tertile 2 -0.063 (1.28)   0.566  0.183 (1.29) 0.120
        RDW tertile 3  0.435 (1.21) <0.001  0.366 (1.46) 0.004
    Healthy controls
        RDW tertile 2 -0.121 (0.85)   0.215 -0.025 (0.92) 0.805
        RDW tertile 3  0.240 (0.81)   0.013  0.056 (1.09) 0.646
CHF, chronic heart failure; RDW, red cell distribution width; SE, standard error.
Adjusted for age, sex, body mass index, hemoglobin, albumin, estimated glomerular filtration rate, left ventricular ejection fraction and E/E’. RDW tertile 1 
as a reference.
Table 5. Comparison of a Model with RDW (Full Model) and a Model without RDW (Reduced Model)
Goodness of fit statistics
Peak VO2 VE/VCO2 slope
R2 Adjusted R2 RMSE R2 Adjusted R2 RMSE
Model 1 (full model) 0.457 0.376 5.110 0.387 0.295 4.522
Model 2 (reduced model) 0.419 0.352 5.208 0.305 0.224 4.743
RMSE, root mean square error; RDW, red cell distribution width.
Model 1: adjusted for age, male gender, body mass index, hemoglobin, albumin, estimated glomerular filtration rate, left ventricular ejection fraction, E/E’, 
RDW tertile. Model 2: adjusted for age, male gender, body mass index, hemoglobin, albumin, estimated glomerular filtration rate, left ventricular ejection 
fraction, E/E’.
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related to the degree of inflammatory activity and catabo-
lism. The relationship between chronic inflammation and 
exercise capacity is well established not only in CHF but 
also in respiratory diseases such as chronic obstructive pul-
monary disease and cystic fibrosis.26 Chronic inflammation 
results in anemia, muscle mass loss, and is associated with 
decreased lung volumes.18,27 Therefore, it is plausible that 
chronic inflammation may play an important pathophysio-
logical role in exercise intolerance and ventilatory ineffi-
ciency in patients with CHF. In the present study, we dem-
onstrate that increased RDW, which can represent chronic 
inflammation, is associated with exercise intolerance and 
ventilatory inefficiency in patients with CHF. Increased 
RDW can be a further indication of more severe HF and is 
associated with ventilatory inefficiency as well as exercise 
intolerance. Interestingly, when we analyzed the healthy 
controls, RDW was higher than patients with CHF. Further-
more, RDW did not have significant correlation with peak 
VO2 or VE/VCO2 slope. Thus, these data can further sup-
port our suggestion that increased RDW in the patients with 
CHF as a result of inflammation could be associated with 
exercise intolerance and ventilatory inefficiency.
Interestingly, despite the selection criteria of the healthy 
controls without any cardiovascular risk factors such as hy-
pertension, diabetes or dyslipidemia, we found that the high-
est tertile groups in the healthy controls were older and had 
lower hemoglobin and albumin levels. Thus, the above 
mechanisms could be applied to the healthy controls as well.
Consistent with our findings, Van Craenenbroeck, et al.28 
previously reported that higher RDW was negatively corre-
lated with peak VO2 and positively correlated with VE/VCO2 
and ventilatory inefficiency with higher VE/VCO2 slope in 
patients with CHF, 2) in contrast to patients with CHF, RDW 
is not related to exercise capacity or ventilatory inefficiency 
in healthy controls, and 3) RDW is an independent predic-
tor of peak VO2 and VE/VCO2 slope when controlling for 
other confounding variables in patients with HF. 
Among various prognostic markers for CHF, increased 
RDW has emerged as an additional predictor of poor out-
comes, especially for patients with HF. It is known that 
RDW is typically high when red cell production is not ef-
fective, such as iron deficiency, vitamin B12 or folate defi-
ciency.21-23 Although the reasons for higher RDW and poor 
prognosis in HF is not fully understood, some explanations 
have been suggested. Persistent inflammation has been 
known to predict progressive illness, cardiovascular mortali-
ty, and death in HF.9 Systemic inflammatory response could 
affect iron metabolism or bone marrow dysfunction. Pro-in-
flammatory cytokines have been found to inhibit erythropoi-
etin-induced erythrocyte maturation and proliferation and 
down regulate erythropoietin receptor expression, which is 
associated with increases in RDW.10,11 Also, RDW may serve 
as an integrative measure of multiple processes simultane-
ously occurring in CHF, such as kidney dysfunction, hepat-
ic congestion, and nutritional deficiencies.6,12 Therefore, in-
creased RDW in CHF might be representative of chronic 
inflammation, and this can lead to poor prognosis in pa-
tients with CHF who have higher RDW.
Chronic inflammation plays a key role in HF pathophysi-
ology, and it is known to be more pronounced in advanced 
disease stages.24,25 Also, Thierer, et al.18 reported that the 
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Fig. 1. Receiver operating characteristic curve of RDW for the determination of peak VO2 ≤20 mL/kg/min and VE/VCO2 slope ≥34. ROC curve indicated a good 
power of RDW in identifying patients with peak VO2 ≤20 mL/kg/min (A) and VE/VCO2 slope ≥34 (B) (AUC 0.717, 95% CI=0.556-0.878 for peak VO2 and AUC 0.858, 
95% confidence interval=0.747-0.970). The optimal cutoff value of RDW for predicting peak VO2 ≤20 mL/kg/min and VE/VCO2 slope ≥34 was 13.6% (sensitivity 
53%, specificity 89%) and 13.4% (sensitivity 75%, specificity 82%). RDW, red cell distribution width; ROC, receiver operating characteristic; CI, confidence in-
terval; AUC, area under the curve.
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not available in our study. Fourth, there was a time interval 
between the laboratory test (RDW) and CPET, although we 
excluded patients whose interval was longer than 3 months. 
In conclusion, higher RDW is independently related to 
exercise intolerance and ventilatory inefficiency in patients 
with CHF, but not in healthy controls. Based on our find-
ings in measuring RDW, which is inexpensive and easily 
performed, it might help predict functional capacity and ven-
tilatory efficiency in CHF patients. Further investigations are 
needed to determine whether increased RDW plays a patho-
physiological role in exercise intolerance or ventilatory in-
efficiency in CHF patients. 
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